2l9m
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Structure of cIAP1 CARD== | ==Structure of cIAP1 CARD== | ||
- | <StructureSection load='2l9m' size='340' side='right'caption='[[2l9m | + | <StructureSection load='2l9m' size='340' side='right'caption='[[2l9m]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2l9m]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[2l9m]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2L9M OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2L9M FirstGlance]. <br> |
- | </td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2l9m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l9m OCA], [https://pdbe.org/2l9m PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2l9m RCSB], [https://www.ebi.ac.uk/pdbsum/2l9m PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2l9m ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2l9m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l9m OCA], [https://pdbe.org/2l9m PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2l9m RCSB], [https://www.ebi.ac.uk/pdbsum/2l9m PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2l9m ProSAT]</span></td></tr> | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/BIRC2_HUMAN BIRC2_HUMAN] Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, TRAF2, DIABLO/SMAC, MAP3K14/NIK, MAP3K5/ASK1, IKBKG/NEMO and MXD1/MAD1. Can also function as an E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Can stimulate the transcriptional activity of E2F1. Plays a role in the modulation of the cell cycle.<ref>PMID:15665297</ref> <ref>PMID:18082613</ref> <ref>PMID:21145488</ref> <ref>PMID:21653699</ref> <ref>PMID:21931591</ref> | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 22: | Line 21: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Day | + | [[Category: Day CL]] |
- | [[Category: Hinds | + | [[Category: Hinds MG]] |
- | [[Category: Rautureau | + | [[Category: Rautureau GJP]] |
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 08:27, 18 January 2023
Structure of cIAP1 CARD
|